Regulus Therapeutics
RGLS
#8818
Rank
NZ$0.16 B
Marketcap
$2.51
Share price
5.00%
Change (1 day)
13.78%
Change (1 year)

Regulus Therapeutics (RGLS) Fails to deliver data

Key failure to deliver metrics for Regulus Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regulus Therapeutics (RGLS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regulus Therapeutics (RGLS) - since 2022

Volume in USD (price x number of shares), data since 2022

Regulus Therapeutics (RGLS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$6.36 M4094.23%
2023NZ$0.15 M-85.22%
2022NZ$1.02 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$25.89 MNZ$55.2 M๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$11.64 MNZ$71.88 M๐Ÿ‡ซ๐Ÿ‡ท France
NZ$7.66 MNZ$69.08 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.61 MNZ$0.16 B๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$10.34 MNZ$44.1 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.43 MNZ$4.04 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.95 MNZ$0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA